Persistent Asset Partners LTD Corcept Therapeutics Inc Transaction History
Persistent Asset Partners LTD
- $121 Billion
- Q4 2024
A detailed history of Persistent Asset Partners LTD transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Persistent Asset Partners LTD holds 1 shares of CORT stock, worth $65. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$65% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CORT
# of Institutions
403Shares Held
84.3MCall Options Held
1.04MPut Options Held
1.33M-
Black Rock Inc. New York, NY16.5MShares$1.08 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$658 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$527 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$403 Million0.49% of portfolio
-
Parallel Advisors, LLC3.83MShares$249 Million4.44% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $6.97B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...